Medigen Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $645K

  • Investors
  • 6

Medigen General Information


Developer of infectious diseases vaccines designed to fight against virus cells. The company's vaccines are developed by applying scientific knowledge of viruses, processes, and immune systems to discover, develop, and commercialize new biopharmaceutical products and also provides contract research services, including experiment design, intellectual property development, and publishing, enabling clients to develop medications for deadly diseases and treat their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Corporate Office
  • 8420 Gas House Pike
  • Suite S
  • Frederick, MD 21701
  • United States
+1 (301) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medigen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Mar-2022 $645K Completed Generating Revenue
4. Grant 03-Apr-2020 00000 Completed Generating Revenue
3. Grant 11-Apr-2018 00000 Completed Generating Revenue
2. Grant 01-Jan-2018 $4.73M Completed Generating Revenue
1. Accelerator/Incubator 30-May-2013 Completed Startup
To view Medigen’s complete valuation and funding history, request access »

Medigen Executive Team (2)

Name Title Board Seat Contact Info
David Newton Chief Executive Officer
Peter Pushko MD Founder, President & Chief Scientific Officer
To view Medigen’s complete executive team members history, request access »

Medigen Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government 000 0000 000000 0
National Institute for Allergy and Infectious Disease Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
United States Department of Agriculture Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Medigen Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Texas BioGene 01-Jan-2004 0000000000 Other Pharmaceuticals and Biotechnology
To view Medigen’s complete acquisitions history, request access »

Medigen Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Texas BioGene 01-Jan-2004 000000000000000000 Completed
  • 0000000
To view Medigen’s complete exits history, request access »

Medigen FAQs

  • When was Medigen founded?

    Medigen was founded in 2004.

  • Who is the founder of Medigen?

    Peter Pushko MD is the founder of Medigen.

  • Who is the CEO of Medigen?

    David Newton is the CEO of Medigen.

  • Where is Medigen headquartered?

    Medigen is headquartered in Frederick, MD.

  • What industry is Medigen in?

    Medigen’s primary industry is Drug Discovery.

  • Is Medigen a private or public company?

    Medigen is a Private company.

  • What is Medigen’s current revenue?

    The current revenue for Medigen is 00000.

  • Who are Medigen’s investors?

    National Cancer Institute, National Institute for Allergy and Infectious Disease, National Institutes of Health, United States Department of Agriculture, and U.S. Department of Health and Human Services are 5 of 6 investors who have invested in Medigen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »